This invention relates to cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives that bind with high selectively and/or high affinity to the benzodiazepine site of GABA
A
receptors. This invention also relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in the treatment of central nervous system (CNS) diseases. This invention also relates to the use of these cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives in combination with one or more other CNS agents to potentiate the effects of the other CNS agents. Additionally this invention relates to the use such compounds as probes for the detection of GABA
A
receptors in tissue samples.
本发明涉及环烷基
吡咯烷-3-
羧酸衍
生物和杂环烷基
吡咯烷-3-
羧酸衍
生物,它们与
GABAA受体的苯二氮平位点具有高选择性和/或高亲和力。本发明还涉及包括这些化合物的制药组合物,并且涉及将这些化合物用于治疗中枢神经系统(CNS)疾病。本发明还涉及将这些环烷基
吡咯烷-3-
羧酸衍
生物和杂环烷基
吡咯烷-3-
羧酸衍
生物与一种或多种其他CNS药剂结合使用,以增强其他CNS药剂的效果。此外,本发明还涉及将这些化合物用作探针,用于检测组织样品中的
GABAA受体。